NASDAQ:CPTS - Bayer Essure Stock Price, Price Target & More

Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Bayer Essure (NASDAQ:CPTS)

Bayer Essure logoConceptus, Inc. designs, develops, markets and promotes solutions in women's healthcare. The Company's flagship product is the Essure permanent birth control procedure, which is the non-surgical permanent birth control system. The Essure delivers a soft and flexible insert into a woman's fallopian tubes, causing a benign tissue in-growth, which blocks the fallopian tubes. Successfully placed Essure inserts and the subsequent tissue growth around, and through the inserts prohibits the egg from traveling through the fallopian tube, preventing conception. In October 2011, the Company acquired from its Dutch distributor certain assets and all distribution rights of the Essure device. In October 2011, it purchased certain assets of Sigma Medical and established a wholly owned subsidiary in the Netherlands, Conceptus B.V. (BV). During the year ended December 31, 2011, approximately 600,000 women worldwide have undergone the Essure procedure.

Receive CPTS News and Ratings via Email

Sign-up to receive the latest news and ratings for CPTS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryHealth Care Equipment
SectorN/A
SymbolNASDAQ:CPTS
CUSIP20601610
Phone+1-302-6365400

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A

How to Become a New Pot Stock Millionaire

Bayer Essure (NASDAQ:CPTS) Frequently Asked Questions

What is Bayer Essure's stock symbol?

Bayer Essure trades on the NASDAQ under the ticker symbol "CPTS."

Has Bayer Essure been receiving favorable news coverage?

News articles about CPTS stock have trended somewhat positive recently, according to Accern Sentiment Analysis. The research firm identifies negative and positive press coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Bayer Essure earned a media sentiment score of 0.05 on Accern's scale. They also assigned media coverage about the healthcare company an impact score of 47.60 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the near future.

How do I buy shares of Bayer Essure?

Shares of CPTS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact Bayer Essure?

Bayer Essure's mailing address is 100 Bayer Rd, PITTSBURGH, PA 15205-9707, United States. The healthcare company can be reached via phone at +1-302-6365400.


MarketBeat Community Rating for Bayer Essure (CPTS)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  102 (Vote Outperform)
Underperform Votes:  76 (Vote Underperform)
Total Votes:  178
MarketBeat's community ratings are surveys of what our community members think about Bayer Essure and other stocks. Vote "Outperform" if you believe CPTS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CPTS will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Bayer Essure (NASDAQ:CPTS) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
(Data available from 4/25/2016 forward)

Earnings

Bayer Essure (NASDAQ:CPTS) Earnings History and Estimates Chart

Earnings by Quarter for Bayer Essure (NASDAQ:CPTS)

Bayer Essure (NASDAQ CPTS) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/30/2013Q1 2013$0.05$31.94 million$34.10 millionViewN/AView Earnings Details
2/5/2013Q4 2012$0.11$0.17$40.20 million$40.73 millionViewN/AView Earnings Details
10/23/2012$0.06$0.07ViewN/AView Earnings Details
4/26/2012($0.13)($0.09)ViewN/AView Earnings Details
2/23/2012$0.02($0.08)ViewN/AView Earnings Details
10/25/2011$0.02($0.09)ViewN/AView Earnings Details
8/4/2011$0.01ViewN/AView Earnings Details
5/10/2011($0.05)($0.09)ViewN/AView Earnings Details
2/24/2011$0.18$2.66ViewN/AView Earnings Details
10/28/2010Q3 2010$0.06$0.10ViewN/AView Earnings Details
8/5/2010Q2 2010($0.01)ViewN/AView Earnings Details
4/20/2010Q1 2010($0.08)($0.08)ViewN/AView Earnings Details
2/23/2010Q4 2009$0.21$0.21ViewN/AView Earnings Details
10/21/2009Q3 2009$0.09$0.24ViewN/AView Earnings Details
7/22/2009Q2 2009($0.05)($0.02)ViewN/AView Earnings Details
4/21/2009Q1 2009($0.15)($0.14)ViewN/AView Earnings Details
2/17/2009Q4 2008$0.18$0.17ViewN/AView Earnings Details
10/29/2008Q3 2008$0.07$0.10ViewN/AView Earnings Details
7/23/2008Q2 2008($0.04)($0.05)ViewN/AView Earnings Details
5/6/2008Q1 2008($0.17)($0.21)ViewN/AView Earnings Details
2/19/2008Q4 2007($0.08)($0.09)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Bayer Essure (NASDAQ:CPTS) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Bayer Essure (NASDAQ CPTS) Insider Trading and Institutional Ownership History

Insider Trading History for Bayer Essure (NASDAQ:CPTS)

Bayer Essure (NASDAQ CPTS) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/9/2013Peter WilsonDirectorSell30,000$25.00$750,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Bayer Essure (NASDAQ CPTS) News Headlines

Source:
No headlines for this company have been tracked by MarketBeat.com

SEC Filings

Bayer Essure (NASDAQ:CPTS) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Bayer Essure (NASDAQ:CPTS) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Bayer Essure (NASDAQ CPTS) Stock Chart for Wednesday, April, 25, 2018

Loading chart…

This page was last updated on 4/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.